Fucoidan / T-Cell Cancer Research Results

F, Fucoidan: Click to Expand ⟱

Features:

Fucoidan is found in brown algae. Extracted from the seaweed species Fucus vesiculosus, Cladosiphon okamuranus, Laminaria japonica and Undaria pinnatifida.
In oncology research, fucoidan is most consistently described as an immunomodulatory and anti-angiogenic compound with additional pro-apoptotic and anti-metastatic effects in preclinical models. Mechanistically, fucoidan has been reported to suppress NF-κB and PI3K/AKT signaling, reduce VEGF-mediated angiogenesis, inhibit tumor cell adhesion and invasion, and promote apoptosis through caspase activation and mitochondrial pathways. It may also enhance NK cell and macrophage activity, contributing to anti-tumor immune responses. Effects vary substantially depending on molecular weight, sulfation pattern, and source species. Human clinical data remain limited, and many anticancer claims are derived from in vitro and animal studies.

Cancer Pathway Table: Fucoidan

Rank	Pathway / Axis	Cancer / Tumor Context	Normal Tissue Context	TSF	Primary Effect	Notes / Interpretation
1	Immune activation (NK cells / macrophages)	NK activity ↑; macrophage activation ↑ (reported)	Immune surveillance support	R, G	Immunostimulatory	One of the most consistent themes; fucoidan enhances innate immune responses in tumor-bearing animal models.
2	NF-κB inflammatory / survival signaling	NF-κB ↓; cytokines ↓ (reported)	Inflammatory tone modulation	R, G	Anti-inflammatory / anti-survival	Suppression of NF-κB contributes to reduced tumor-promoting inflammation and survival signaling.
3	PI3K → AKT signaling	PI3K/AKT ↓; proliferation ↓ (model-dependent)	↔	R, G	Growth signaling suppression	Reported in multiple cancer cell models; often secondary to upstream immune or redox modulation.
4	Intrinsic apoptosis (mitochondrial pathway)	Caspases ↑; Bax ↑; Bcl-2 ↓ (reported)	Minimal apoptosis in normal cells (dose-dependent)	G	Apoptotic induction	Apoptosis frequently reported in vitro; magnitude depends on molecular weight and sulfation.
5	Angiogenesis (VEGF signaling)	VEGF ↓; angiogenesis ↓ (reported)	↔	G	Anti-angiogenic	Anti-angiogenic activity is one of the more reproducible findings in preclinical systems.
6	Metastasis / adhesion (selectins, ECM interaction)	Tumor adhesion ↓; invasion ↓ (reported)	↔	G	Anti-metastatic	Sulfated structure may interfere with selectin-mediated adhesion and tumor cell migration.
7	ROS / redox modulation	ROS modulation (context-dependent)	Antioxidant protection reported	P, R	Redox modulation (secondary)	Fucoidan is not a primary pro-oxidant; redox effects appear secondary to signaling changes.
8	Chemo / radiation synergy	Sensitization ↑ (reported in models)	↔	G	Adjunct potential	May enhance cytotoxic therapy response; evidence largely preclinical.
9	Warburg metabolism	Indirect modulation (not a primary glycolysis inhibitor)	↔	R	Metabolic secondary effect	Metabolic changes likely downstream of survival pathway suppression rather than direct glycolysis blockade.
10	Bioavailability / heterogeneity constraint	Effects vary by molecular weight and source	Generally well tolerated orally	—	Translation constraint	Composition varies widely by seaweed species and extraction method; standardization is critical.

TSF: P = 0–30 min (surface receptor interactions), R = 30 min–3 hr (immune and signaling shifts), G = >3 hr (apoptosis, angiogenesis, immune outcomes).

T-Cell, T lymphocytes: Click to Expand ⟱

Source:

Type: white blood cell

T cells are white blood cells that play a central role in the adaptive immune response.
Subsets and Function:
Cytotoxic T Cells (CD8+): Recognize and kill infected or malignant cells.
Helper T Cells (CD4+): Assist in orchestrating the immune response by secreting cytokines and supporting the functions of other immune cells.
T cells, particularly CD8+ cytotoxic T cells, can recognize tumor antigens presented on major histocompatibility complex (MHC) molecules and directly kill malignant cells.
Regulatory T Cells (Tregs): Maintain immune tolerance and prevent autoimmunity but may also suppress anti-tumor responses in the tumor microenvironment.
Tumor-Infiltrating Lymphocytes (TILs):
Tumor Microenvironment:
The presence of T cells within tumors, often referred to as tumor-infiltrating lymphocytes, is a key indicator of an ongoing anti-tumor immune response.
Regulatory T Cells (Tregs):
Tregs within the tumor environment may inhibit the activity of cytotoxic T cells through the secretion of immunosuppressive cytokines (e.g., IL-10, TGF-β), thus allowing tumors to evade the immune response.

In many cancers, a robust T cell infiltrate is correlated with a better overall survival, lower rates of relapse, and improved responses to therapy.
Assessing the type, density, and activation state of T cells in the tumor microenvironment can provide valuable prognostic information. High levels of active, cytotoxic T cells generally indicate a better prognosis.

Scientific Papers found: Click to Expand⟱

1038-

immuno,

Fucoidan enhances the anti-tumor effect of anti-PD-1 immunotherapy by regulating gut microbiota.

in-vivo,

BC,

GutMicro↑, T-Cell↑, Treg lymp↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Migration ⓘ

Treg lymp↓, 1,

Immune & Inflammatory Signaling ⓘ

T-Cell↑, 1,

Clinical Biomarkers ⓘ

GutMicro↑, 1,
Total Targets: 3

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: T-Cell, T lymphocytes

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:81  Target#:300  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid